Sun Pharmaceutical Executive Chairman Dilip Shanghvi addresses a press conference in Mumbai on April 27, 2026. India's Sun Pharmaceutical on April 27 said it had agreed to buy women's healthcare firm Organon in a deal that values the US drugmaker at $11.75 billion. (Photo by Punit PARANJPE / AFP via Getty Images)